Hi [[ session.user.profile.firstName ]]

World Intellectual Property Review Insights

  • Date
  • Rating
  • Views
  • Actavis and equivalence – where are we now?
    Actavis and equivalence – where are we now?
    Douglas Drysdale, partner, HGF Recorded: Oct 11 2018 63 mins
    The UK Supreme Court's 2017 decision in Actavis v Eli Lilly introduced a doctrine of equivalents into UK law. In this webinar, we'll discuss the implications of that decision and look at how it is being applied in other cases in the UK courts.
  • Second Medical Use Patent Opportunities from Personalised Healthcare Inventions
    Second Medical Use Patent Opportunities from Personalised Healthcare Inventions
    Dr. Laurence Gainey, Patent Director, HGF Recorded: Sep 11 2018 58 mins
    Personalised healthcare (sometimes referred to as precision medicine) is an evolving field in medicine where a therapeutic treatment is tailored to an individual with a particular disease. The patenting of personalised healthcare inventions has proved problematic in a number of jurisdictions, most notably the USA. However, various aspects of these inventions are patentable in Europe.

    This webinar will set the scene as to what personalised healthcare is and will run through the history of second medical use patenting in Europe. Discussing key cases such as G5/83, T1020/03 and G2/08.

    It will then focus on how second medical use patenting can be applied to personalised healthcare inventions and will give examples of claim language that is finding favour at the EPO.
  • CRISPR: Updates and trends in opposition and appeal practice before the EPO
    CRISPR: Updates and trends in opposition and appeal practice before the EPO
    Catherine Coombes (HGF), Dr. Chris Moore (HGF), Peter Scott (WIPR) Recorded: Mar 21 2018 42 mins
    This webinar will be on opposition and appeals practice before the EPO. We’ll be discussing the streamlining of the opposition procedure by the EPO, the changes that we are seeing as a result and will be providing practical tips in view of these changes. The talk will also draw on recent case law.
  • Protecting the Pot of Gold: Patent Applications for Therapeutic Antibodies
    Protecting the Pot of Gold: Patent Applications for Therapeutic Antibodies
    Gerald Murphy (BSKB), John Heithaus (BSKB), Peter Scott (WIPR) Recorded: Jan 30 2018 63 mins
    Over the last 10 years, multiple patents on therapeutic antibodies have been invalidated in the courts, often for lack of written description. Many other cases are working their way through the courts and the PTAB. This webinar will review major CAFC and PTAB decisions affecting therapeutic antibodies and will explore the best ways to obtain valuable and enforceable patents on therapeutic antibodies. The main issues to be covered are Section 101 issues (laws of nature, natural phenomena and natural products), obviousness and written description.
  • Saving money immediately on your IP assets: Auditing your trademark portfolio
    Saving money immediately on your IP assets: Auditing your trademark portfolio
    Guido Chiavelli (CEO, Il Gufo), Alessia Parassina (Lawyer, Brandstock), Angela La Marca (IP counsel) Ed Conlon (WIPR), Recorded: Oct 26 2017 58 mins
    With the year approaching its end, many IP departments will be looking at how best to rationalise their work for 2018. This webinar explores how to ensure your trademark portfolio is in the best possible shape using a two part verification and audit process to save you time and money on your IP assets, as well as analyzing your current and planned costs and guiding your filing strategy in the new year.
  • WIPR and RWS IP Services present: 10 Steps for Managing Your Patents in China
    WIPR and RWS IP Services present: 10 Steps for Managing Your Patents in China
    Caroline Chenique (Global Director of Sales & Marketing, RWS), Justin Simpson (RWS, founder of inovia) and Ed Conlon (WIPR) Recorded: Oct 17 2017 42 mins
    Join WIPR and RWS IP Services for a complimentary webinar as we discuss patent filing strategies in China.

    As the largest growing consumer market in the world, enforcing your intellectual property (IP) in China has become increasingly critical. In this webinar, we will discuss the ten steps your organization should take when seeking patent protection and help you formulate your commercial IP strategy.
  • WIPR and HGF present: Biotech patentability issues in Europe
    WIPR and HGF present: Biotech patentability issues in Europe
    Iain Armstrong (Partner, HGF), Dr. Laurence Gainey (Patent Director, HGF) and Peter Scott (Publisher, WIPR/LSIPR) Recorded: Sep 27 2017 58 mins
    This webinar will cover the current state of play in Europe regarding biotech patentability issues, including recent case law on what data you need to make an invention in this area plausible. It will also look at how recent rule changes have influenced patentability of plants and animals before the EPO. Finally, we will compare patentability practice in different jurisdictions around the world, most notably in the US, China and Japan.
  • The jungle of IP ownership: How to manage your IP Recordals
    The jungle of IP ownership: How to manage your IP Recordals
    Anna Popova (Brandstock), Ingo Dauer (L'Occitane en Provence), Sandra Hammelmann (Abbott), Peter Scott (WIPR) Recorded: Jun 27 2017 59 mins
    WIPR and Brandstock present this one hour webinar looking at IP recordals projects and the challenges brands face when undertaking this kind of work.
  • WIPR and BSKB present: The Halo effect: walking the willfulness tightrope
    WIPR and BSKB present: The Halo effect: walking the willfulness tightrope
    Peter Scott (WIPR), Michael Mutter (BSKB), Shawn Hamidinia (BSKB) Recorded: May 16 2017 57 mins
    The US Supreme Court's recent decision in Halo Electronics, Inc. v. Pulse Electronics, Inc has big implications.

    This one-hour webinar will briefly address the history of willful infringement and the obligations to avoid infringement before and after the Seagate decision and as changed by Halo.

    It will also focus on how to best establish good faith with a non-infringement/invalidity position post-Halo including where a product was introduced post-Seagate and prior to Halo.
  • LSIPR and HGF present: Navigating the CRISPR IP landscape in Europe
    LSIPR and HGF present: Navigating the CRISPR IP landscape in Europe
    Dr Claire Irvine (HGF Ltd) Catherine Coombes (HGF Ltd), Peter Scott (Life Sciences IP Review) Recorded: Apr 25 2017 52 mins
    The CRISPR IP landscape in Europe is very murky. Listeners will gain an understanding of the current situation, which will aid them to make licensing decisions if and when they intend to commercialise. This 45-minute webinar will provide an up to date analysis of the current state of play in Europe with comparison to the state of play in the US.

Embed in website or blog